Your browser doesn't support javascript.
loading
Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.
Gupte, A N; Selvaraju, S; Paradkar, M; Danasekaran, K; Shivakumar, S V B Y; Thiruvengadam, K; Dolla, C; Shivaramakrishnan, G; Pradhan, N; Kohli, R; John, S; Raskar, S; Jain, D; Momin, A; Subramanian, B; Gaikwad, A; Lokhande, R; Suryavanshi, N; Gupte, N; Salvi, S; Murali, L; Checkley, W; Golub, J E; Bollinger, R; Chandrasekaran, P; Mave, V; Gupta, A.
Affiliation
  • Gupte AN; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Selvaraju S; National Institute for Research in Tuberculosis, Chennai.
  • Paradkar M; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Danasekaran K; National Institute for Research in Tuberculosis, Chennai.
  • Shivakumar SVBY; Johns Hopkins University India Office, Pune.
  • Thiruvengadam K; National Institute for Research in Tuberculosis, Chennai.
  • Dolla C; National Institute for Research in Tuberculosis, Chennai.
  • Shivaramakrishnan G; National Institute for Research in Tuberculosis, Chennai.
  • Pradhan N; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Kohli R; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • John S; National Institute for Research in Tuberculosis, Chennai.
  • Raskar S; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Jain D; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Momin A; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Subramanian B; National Institute for Research in Tuberculosis, Chennai.
  • Gaikwad A; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Lokhande R; Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune.
  • Suryavanshi N; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.
  • Gupte N; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Salvi S; Chest Research Foundation, Pune, India.
  • Murali L; National Institute for Research in Tuberculosis, Chennai.
  • Checkley W; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Golub JE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bollinger R; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Chandrasekaran P; National Institute for Research in Tuberculosis, Chennai.
  • Mave V; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gupta A; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Int J Tuberc Lung Dis ; 23(4): 450-457, 2019 04 01.
Article in En | MEDLINE | ID: mdl-31064624
ABSTRACT
id="st1"> BACKGROUND The association between respiratory impairment and tuberculosis (TB) treatment outcomes is not clear. id="st2"> <a class="decs" id="22045">METHODS</a> We prospectively evaluated respiratory health status, measured using the Saint George's Respiratory Questionnaire (SGRQ), in a cohort of new adult pulmonary TB cases during and up to 18 months following treatment in India. Associations between total SGRQ scores and poor treatment outcomes of failure, recurrence and all-cause death were measured using multivariable Poisson regression. id="st3"> RESULTS We enrolled 455 participants contributing 619 person-years at risk; 39 failed treatment, 23 had recurrence and 16 died. The median age was 38 years (interquartile range 26-49); 147 (32%) ever smoked. SGRQ scores at treatment initiation were predictive of death during treatment (14% higher risk per 4-point increase in baseline SGRQ scores, 95%CI 2-28, P = 0.01). Improvement in SGRQ scores during treatment was associated with a lower risk of failure (1% lower risk for every per cent improvement during treatment, 95%CI 1-2, P = 0.05). Clinically relevant worsening in SGRQ scores following successful treatment was associated with a higher risk of recurrence (15% higher risk per 4-point increase scores, 95%CI 4-27, P = 0.004). id="st4"> CONCLUSION Impaired respiratory health status was associated with poor TB treatment outcomes. The SGRQ may be used to monitor treatment response and predict the risk of death in pulmonary TB. .
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Health Status Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2019 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Health Status Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2019 Document type: Article Affiliation country: Estados Unidos